FDA — authorised 4 April 1978
- Marketing authorisation holder: MYLAN INSTITUTIONAL
- Status: approved
🇺🇸 Rimso-50 in United States
FDA authorised Rimso-50 on 4 April 1978
Marketing authorisations
FDA — authorised 4 April 1978
- Application: NDA017788
- Marketing authorisation holder: MYLAN INSTITUTIONAL
- Local brand name: RIMSO-50
- Indication: SOLUTION — INTRAVESICAL
- Status: approved
Rimso-50 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in United States
Frequently asked questions
Is Rimso-50 approved in United States?
Yes. FDA authorised it on 4 April 1978; FDA authorised it on 4 April 1978.
Who is the marketing authorisation holder for Rimso-50 in United States?
MYLAN INSTITUTIONAL holds the US marketing authorisation.